NCT02502253 BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE1
NCT02502045 Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's Status COMPLETED Phase NA
NCT02500784 Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease Status WITHDRAWN Phase PHASE2
NCT02492529 Knowing and Remembering: Cognitive and Neural Influences of Familiarity on Recognition Memory in Early Alzheimer's Disease Status COMPLETED Phase NA
NCT02485730 Early Identification of Markers in Alzheimer's Families / ALFA Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02484547 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT02477800 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT02471833 Health Evaluation in African Americans Using RAS Therapy Status COMPLETED Phase PHASE1/PHASE2
NCT02471196 Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT02467413 BAC in Patient With Alzheimer's Disease or Vascular Dementia Status WITHDRAWN Phase PHASE2
NCT02462161 Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart Status COMPLETED Phase PHASE1
NCT02460783 Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function Status COMPLETED Phase NA
NCT02438202 Electroconvulsive Therapy for Treatment of Alzheimer´s Disease Status NOT_YET_RECRUITING Phase NA
NCT02434718 Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT02431468 A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Status COMPLETED Phase PHASE2